ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
NewAmsterdam Pharma Company NV

NewAmsterdam Pharma Company NV (NAMSW)

14.78
0.00
( 0.00% )
Updated: 13:36:15

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)
Total Assets 0347.1M488.46M446.69M439.19M
Total Current Assets 0346.79M487.82M445.35M437.87M
Cash and Equivalents 0340.45M481.15M430.71M422.73M
Total Non-Current Assets 0306k641k1.34M1.32M
Total Liabilities 058.7M76.66M59.25M60.33M
Total Current Liabilities 049.9M59.73M45.31M41.26M
Total Non-Current Liabilities 08.81M16.93M13.94M19.07M
Common Equity 010.17M11.11M11.15M11.44M
Retained Earnings 0-316.97M-410.74M-449.75M-466.39M
Year End December 30 2023 2023
USD (US$)
Total Assets 347.1M
Total Current Assets 346.79M
Cash and Equivalents 340.45M
Total Non-Current Assets 288.39M
Total Liabilities 58.7M
Total Current Liabilities 49.9M
Total Non-Current Liabilities 8.81M
Total Equity 288.39M
Common Equity 10.17M
Retained Earnings -316.97M

Your Recent History

Delayed Upgrade Clock